左乙拉西坦
治疗指标
治疗药物监测
航程(航空)
参考范围
医学
治疗效果
药品
内科学
药理学
精神科
癫痫
工程类
航空航天工程
作者
Sylvain Couderc,Mondher Chouchane,Franck Saint‐Marcoux
标识
DOI:10.1097/ftd.0000000000000972
摘要
The Therapeutic Drug Monitoring guidelines of Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie had proposed a therapeutic reference range of 10-40 mg/L for levetiracetam in 2011. In the first version of the 2017 update, it was changed to 20-40 mg/L; however, 5 months later, in an erratum version, it was changed back to 10-40 mg/L. In this study, the authors agree with the range to 10-40 mg/L but discuss to what extent a wider interval may be proposed for certain patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI